title: [Reactivation of hepatitis B virus in patients with hematological neoplasms].
authors.affiliation: Academisch Medisch Centrum/Universiteit van Amsterdam. r.b.takkenberg@amc.uva.nl
authors.forename: R B
authors.initials: RB
authors.lastname: Takkenberg
authors.forename: Hans L
authors.initials: HL
authors.lastname: Zaaijer
authors.forename: David F
authors.initials: DF
authors.lastname: ten Cate
authors.forename: Bart J
authors.initials: BJ
authors.lastname: Biemond
authors.forename: Peter L M
authors.initials: PL
authors.lastname: Jansen
authors.forename: Henk W
authors.initials: HW
authors.lastname: Reesink
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D006086:Graft vs Host Disease; D019337:Hematologic Neoplasms / Q000276:immunology / Q000628:therapy*; D006509:Hepatitis B / Q000150:complications* / Q000453:epidemiology / Q000821:virology; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D012307:Risk Factors; D012737:Sex Factors; D019737:Transplants; D014775:Virus Activation
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D019259:Lamivudine